Medical Research News

VIEWEDNOW PLAYING

FADING HOPE OMICRON WILL CREATE HERD IMMUNITY

The Omicron variant, which is spreading far faster than previous versions of the coronavirus, is not likely to help countries achieve so-called herd immunity against COVID-19, in which enough peopl...

Reuters

3 days ago

VIEWEDNOW PLAYING

NEW STUDY FINDS FOURTH BOOSTER SHOT 'DOESN'T STOP OMICRON'

Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting c...

Reuters

5 days ago

VIEWEDNOW PLAYING

OMICRON SHOWS SIGNS OF 'PANDEMIC’S END', BUT WITH CAVEATS

There is some optimism the Omicron wave could signal the beginning of the end of the COVID-19 pandemic, but experts also point out many caveats because it's unclear how long immunity lasts and if i...

CBC News

6 days ago

VIEWEDNOW PLAYING

FRANCE LAUNCHES PLAN TO COMBAT ENDOMETRIOSIS

Endometriosis is a condition that affects 1 in 10 women in France and has long been misunderstood or even ignored.

France 24

12 days ago

VIEWEDNOW PLAYING

MAN RECOVERING AFTER ‘BREAKTHROUGH’ PIG HEART TRANSPLANT

A US patient has become the first in the world to have a heart transplant from a genetically-modified pig. Scientists hope pig organs could one day help to alleviate shortages of organ donors.

Al Jazeera

13 days ago

VIEWEDNOW PLAYING

MAN RECEIVES GENETICALLY MODIFIED PIG’S HEART

In a medical first, surgeons successfully transplanted a genetically modified pig’s heart into a U.S. man in a last effort to save his life.

CBC News

13 days ago

VIEWEDNOW PLAYING

MIXED ADVICE OVER TIMING FOR BOOSTER AFTER OMICRON RECOVERY

People who’ve recovered from the Omicron variant are hearing mixed advice about when they should receive their COVID-19 booster shot – shortly after recovery or several weeks later.

CBC News

13 days ago

VIEWEDNOW PLAYING

MODERNA: OVER 50'S WILL NEED ANNUAL BOOSTERS

Moderna says the over 50s and other vulnerable groups may need to have annual boosters to help keep a lid on COVID. Julian Satterthwaite reports.

Reuters

14 days ago

VIEWEDNOW PLAYING

PFIZER, BIONTECH TO DEVELOP MRNA SHINGLES VACCINE

Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies...

Cheddar News

19 days ago

VIEWEDNOW PLAYINGGLOBAL

OMICRON SEEMS TO CAUSE MILDER SYMPTOMS: WHO

More evidence is emerging that the Omicron coronavirus variant is affecting the upper respiratory tract, causing milder symptoms than previous variants, a World Health Organization official said on...

Reuters

20 days ago

VIEWEDNOW PLAYINGGLOBAL

JOHNSON & JOHNSON BOOSTER CUTS SEVERE OMICRON; STUDY

A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant...

Reuters

24 days ago

VIEWEDNOW PLAYING

ISRAEL TESTS SECOND BOOSTER SHOT ON HEALTH WORKERS

An Israeli hospital administered a second round of booster shots to a test group of health workers on Monday, in what it called the first major study into whether the additional boosters will help ...

Reuters

27 days ago

VIEWEDNOW PLAYING

CALLS FOR VACCINE PATENTS TO BE LIFTED TO HELP THIRD-WORLD SUPPLY

One hundred countries have joined a call for vaccine patents to be temporarily waived so developing countries can produce their own. Britain and Germany are among those firmly opposed with the G7 ...

Al Jazeera

29 days ago

VIEWEDNOW PLAYINGBREAKINGGLOBAL

A MONTH SINCE IT WAS DISCOVERED, DOCTORS SAY OMICRON POSES 'MUCH LOWER RISK'

Friday marks a month since South Africa announced the first case of Omicron, and scientists now are developing a clearer picture of its dangers. So far, the data suggests that it is milder than pr...

Al Jazeera

1 month ago

VIEWEDNOW PLAYING

FIRST 'PORTABLE MRI' MACHINE SWOOP GOES TO IPO

Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO l...

Cheddar News

1 month ago

VIEWEDNOW PLAYING

U.S GIVES APPROVAL TO 'LESS EFFECTIVE' MERCK ANTIVIRAL COVID PILL

The U.S on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar but more effective treatment from Pfizer I...

Reuters

1 month ago

VIEWEDNOW PLAYING

ANTIVIRAL PFIZER PILL GETS U.S FDA APPROVAL FOR USAGE

Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an im...

Reuters

1 month ago

VIEWEDNOW PLAYING

ISRAEL FIRST COUNTRY TO OFFER FOURTH BOOSTER DOSE OF COVID VACCINE

Israel has announced it will offer a fourth dose of the COVID-19 vaccine to health workers and people older than 60, amid concern about the spread of the Omicron variant of the coronavirus.

Al Jazeera

1 month ago

VIEWEDNOW PLAYING

UK STUDY FINDS OMICRON SYMPTOMS 'NO LESS SEVERE' THAN DELTA

Infections caused by the Omicron variant of the coronavirus do not appear to be less severe than infections from Delta, according to early data from the UK. This report produced by Tamara Lindstrom.

Reuters

1 month ago

VIEWEDNOW PLAYINGBREAKING

OMICRON NOW THE 'DOMINANT STRAIN' ACROSS U.S

New York officials are trying to calm nerves as Omicron becomes the dominant variant across the state and throughout the U.S.

CBC News

1 month ago

VIEWEDNOW PLAYING

OMICRON MILDER DUE TO VACCINES SAY SOUTH AFRICAN DOCTORS

There have been early anecdotal accounts suggesting that Omicron is causing less severe illness than previous variants in South Africa - something the government attributes to vaccines and a high l...

Reuters

1 month ago

VIEWEDNOW PLAYING

EU TO BUY 'OMICRON TAILORED' PFIZER VACCINE FROM MARCH

EU governments have agreed to buy 180 million shots from Pfizer that have been tailored to combat the Omicron variant of COVID. Julian Satterthwaite reports.

Reuters

1 month ago

VIEWEDNOW PLAYING

STUDY FINDS SOME VACCINES 'LESS EFFECTIVE' AGAINST OMICRON

COVID-19 vaccines from U.S. drugmaker Johnson & Johnson and China's Sinopharm as well as Russia's Sputnik V shot had no neutralizing activity against the Omicron variant, according to a study which...

Reuters

1 month ago

VIEWEDNOW PLAYING

EUROPE APPROVES JOHNSON & JOHNSON COVID BOOSTER

The EU has approved a booster dose of Johnson & Johnson's COVID shot, but Sanofi and GlaxoSmithKline say their new shot could be longer in coming than expected. Edward Baran reports.

Reuters

1 month ago

VIEWEDNOW PLAYING

PFIZER VACCINE 'LESS EFFECTIVE' AGAINST OMICRON

New data gathered in South Africa suggests Pfizer-BioNTech's COVID-19 vaccine is less effective at preventing infections caused by the omicron variant, but the shot is still helpful in preventing h...

CBC News

1 month ago

VIEWEDNOW PLAYING

PFIZER 70% EFFECTIVE AGAINST 'SEVERE OMICRON'; STUDY

Pfizer Inc.'s two-shot vaccine course may provide 70% protection against hospitalization from the Covid-19 omicron variant, according to a study by South Africa's largest medical-insurance provider...

Bloomberg

1 month ago

VIEWEDNOW PLAYING

PFIZER COVID PILL '90% EFFECTIVE IN PREVENTING DEATHS'

Pfizer says tests show its new COVID pill is almost 90% effective in preventing hospitalizations and deaths in high-risk patients. Julian Satterthwaite reports.

Reuters

1 month ago

VIEWEDNOW PLAYING

NEW STUDY FINDS BOOSTER SHOTS 'NEUTRALIZE' OMICRON

As many countries step up their booster vaccine programs, Israeli researchers said on Saturday (December 11) that three shots of the Pfizer/BioNTech vaccine provides ‘significant protection’. Louis...

Reuters

1 month ago

VIEWEDNOW PLAYINGGLOBAL

'BOOSTER SHOT REQUIRED' TO PREVENT OMICRON; STUDY

Booster COVID-19 shots significantly restore protection against mild disease caused by the Omicron variant, in part reversing an otherwise steep drop in vaccine effectiveness, the UK Health Securit...

Reuters

1 month ago

VIEWEDNOW PLAYING

UNDERWHELMING RESULTS FOR MODERNA'S FLU VACCINE

Moderna executives called on investors to wait for more data amid a sharp selloff in its shares on Friday, after early data showed its mRNA-based flu vaccine was no better than already approved sho...

Reuters

1 month ago